Tatsuo Igarashi, Ken Marumo, Tetsuro Onishi, Mikio Kobayashi, Keisuke Aiba, Tomoyasu Tsushima, Seiichiro Ozono, Yoshihiko Tomita, Toshiro Terachi, Yoshiaki Satomi, Juichi Kawamura, and the Japanese Study Group against Renal Cancer. Interferon-alpha and 5-fluorouracil therapy in patients with metastatic renal cell cancer : An open multicenter trial. Urology, 1999; 53 : 53-59
Ken Marumo, Yoshiaki Satomi, Noriomi Miyao, Michihiko Hasegawa, Yoshihiko Tomita, Tasuo Igarashi, Tetsuro Onishi, Hayakazu Nakazawa, Momokuni Fukuda, Seiichiro Ozono, Toshiro Terachi, Tomoyasu Tsushima, Takahisa Nakamoto, Juichi Kawamura and the Japanese Society of Renal Cancer. The prevalence of renal cell carcinoma : A nation-wide survey in Japan. Int J Urol, 2001; 8:359-365
Seiichiro Ozono, Noriomi Miyao, Tatsuo Igarashi, Ken Marumo, Hayakazu Nakazawa, Momokuni Fukuda, Tomoyasu Tsushima, Noriaki Tokuda, Juichi Kawamura, Masaru Murai and Collaboration Group of Japanese Society of Renal Cancer. Tumor doubling time of renal cell carcinoma measured by CT : Collaboration of Japanese Society of Renal Cancer. Jpn J Clin Oncol, 2004; 34(2): 82-85
Tokuda N, Naito S, Matsuzaki O, Nagashima Y, Ozono S, Igarashi T, Japanese Society of Renal Cancer . Collecting Duct (Bellini Duct) Renal Cell Carcinoma: A Nationwide Survey in Japan. J Urol, 2006; 176(1): 40-43
Ken Marumo, Hiroomi Kanayama, Noriomi Miyao, Hayakazu Nakazawa,Seiichiro Ozano, Sigeo Horie, Satoshi Nagamori, Tatsuo Igarashi,Michihiko Hasegawa, Go Kimura, Masahiro Nakao, Takahisa Nakamoto,Seiji Naito, and Japanese Study Group Against Renal Cancer. Prevalence of renal cell carcinoma: A nation-wide survey in japan,2002. Int J Urol, 2007; 14:479-482
Senga Y, Ozono S, Nakazawa H, Nagamori S, Marumo K, Horie S, Onishi T, Miyao N, Nakao M, Igarashi T, Tsushima T, Hasegawa M, Murai M; the Japanese Society of Renal Cancer (JSRC): Surgical outcomes of partial nephrectomy for renal cell carcinoma: A joint study by the Japanese Society of Renal Cancer. Int J Urol. 2007; 14(4):284-248.
Keiichi Ito, Hayakazu Nakazawa, Ken Marumo, Seiichiro Ozono, Tatsuo Igarashi, Nobuo Shinohara, Momokuni Fukuda, Tomoyasu Tsushima, Seiji Naito, and Masamichi Hayakawa. Risk Factors for Ipsilateral Adrenal Involvement in Renal Cell Carcinoma. J Urol, 2008; 72(2): 354-358.
Noriomi Miyao, Seiji Naito, Seiichiro Ozono, Nobuo Shinohara, Naoya Masumori, Tatsuo Igarashi, Masahiro Nakao, Tomoyasu Tsushima, Yutaka Senga, Shigeo Horie, Hiro-omi Kanayama, Noriaki Tokuda, and Mikio Kobayashi, for the Japanese Society of Renal Cancer. Late Recurrence of Renal Cell Carcinoma: Retrospective and Collaborative Study of the Japanese Society of Renal Cancer. Urology 2011; 77(2): 379-384
Masanori Hirono, Mikio Kobayashi, Tomoyasu Tsushima, Wataru Obara, Nobuo Shinohara, Keiichi Ito, Masatoshi Eto, Tatsuya Takayama, Yasuhisa Fujii, Masaharu Nishikido, Go Kimura, Takeshi Kishida, Masayuki Takahashi, Noriomi Miyao, Yukio Naya, Takashige Abe, Tomoaki Fujioka, Kazuto Ito, Seiji Naito, Members of the Japanese Society of Renal Cancer Impacts of clinicopathologic and operative factors on short-term and long-term survival in renal cell carcinoma with venous tumor thrombus extension: a multi-institutional retrospective study in Japan BMC Cancer 2013,13:447
N. Shinohara, N. Nonomura2 M. Eto, G. Kimura, H. Minami, S. Tokunaga , S. Naito A randomized multicenter phase II trial on the efficacy of a hydrocolloid dressing containing ceramide with a low-friction external surface for hand-foot skin reaction caused by sorafenib in patients with renal cell carcinoma. Annals of Oncology 2013 00: 1-5
Tatsugami , Shinohara , Kondo, Yamasaki, Eto, Tsushima, Terachi, Naito; Japanese Society of Renal Cancer. Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era. Int J Urol. 2015 Aug,22(8):736-40. doi: 10.1111/iju.12803. Epub 2015 May 18.
Ito K, Mikami S, Tatsugami K, Masumori N, Shinohara N, Kondo T, Nakanishi S, Nagashima Y, Eto M, Kamba T, Kuroda N, Tomita Y, Matsuyama H, Onishi T, Tsushima T, Nakazawa H, Oya M, Ozono S, Naito S, Asano T. Clinical outcomes in patients with metastatic papillary renal-cell carcinoma: a multi-institutional study in Japan. Clin. Genitourin. Cancer. 2018; 16: e1201-14.
Shuji Mikami, Ryuichi Mizuno, Tsunenori Kondo, Nobuo Shinohara, Norio Nonomura, Seiichiro Ozono, Masatoshi Eto, Katsunori Tatsugami, Tatsuya Takayama, Hideyasu Matsuyama, Takeshi Kishida, Mototsugu Oya, on behalf of the Japanese Society of Renal Cancer. Clinical significance of programmed death‐1 and programmed death‐ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma Cancer Science. 2019;110:1820?1828.
Keiichi Ito, Shuji Mikami, Naoto Kuroda, Yoji Nagashima, Katsunori Tatsugami, Naoya Masumori, Tsunenori Kondo, Toshio Takagi, Shotaro Nakanishi, Masatoshi Eto, Tomomi Kamba, Yoshihiko Tomita, Hideyasu Matsuyama, Tomoyasu Tsushima, Hayakazu Nakazawa, Mototsugu Oya, Go Kimura, Nobuo Shinohara, Tomohiko Asano:
Difficulty in differential diagnosis for renal cancer with microscopic papillary architecture: overlapped pathological features among papillary renal cell carcinoma (RCC), mutinous tubular and spindle cell carcinoma, and unclassified RCC. Lessons from a Japanese multicenter study.
Japanese Journal of Clinical Oncology, 2020, 50(11)1313-1320
学会発表
Tatsuo Igarashi, Ken Marumo, Tetsuro Onishi, Mikio Kobayashi, Keisuke Aiba, Tomoyasu Tsushima, Seiichiro Ozono, Yoshihiko Tomita, Toshiro Terachi, Yoshiaki Satomi, Juichi Kawamura, and the Japanese Study Group against Renal Cancer: Interferon-alpha plus 5-FU therapy in metastatic renal cell cancer: A multicenter trial by the Japanese Study Group against Renal Cell Cancer.
Proceeding of 32nd Annual Meeting of American Society of Clinical Oncology (April, 1996).
Noriaki Tokuda, Seiji Naito, Osamu Matsuzaki, Yoji Nagasima, Seiichiro Ozono, Hayakazu Nakazawa, Masaru Murai and Japanese Society of Renal Cancer: Collecting duct (Bellini duct) renal cell carcinoma: a nation-wide survey in Japan. *The 99th Annual meeting of American Urological Association (May, 2005),San Francisco,USA
Masanori Hirono, Kazuhiro Suzuki, Ito Kazuto, Mikio Kobayashi, Nobuo shinohara, Hiromi Kumon, Masamichi Hayakawa, Seiji Naito, Seiichiro Ozono, Iwao Fukui, Nishikido, Masaharu, Go Kimura, Tatsuo Igarashi: Impact of clinicopathologic and operative factors on short-term and long-term survival in renal cell carcinoma with venous tumor thrombus extension before introducing molecular-targeted therapy: multi-institutional study in Japan. *The 98th Annual Meeting Of Japanese Urological Association (April,2010)
N. Shinohara, N. Nonomura, G. Kimura, M. Eto, H. Minami, N. Yamazaki, S. Naito, Japanese Society of Renal Cancer: A randomized multi-center phase II trial on efficacy of high-slip skin care pad for hand-foot skin reaction caused by sorafenib in patients with renal cell carcinoma. *ASCO 2011 Annual Meeting (June 2011)
Ito K, Mikami S, Tatsugami K, Masumori N, Shinohara N, Kondo T, Nakanishi S, Nagashima Y, Eto M, Kamba T, Kuroda N, Tomita Y, Matsuyama H, Onishi T, Tsushima T, Nakazawa H, Oya M, Ozono S, Naito S, Asano T, Members of JSRC. Clinical outcomes in patients with metastatic papillary renal cell carcinoma (mPRCC): A Japanese multiinstitutionalstudy. The 110 th American Urological Association Meeting, San Diego. 2016
Ito K, Mikami S, Tatsugami K, Masumori N, Shinohara N, Kondo T, Nakanishi S, Nagashima Y, Eto M, Kamba T, Kuroda N, Tomita Y, Matsuyama H, Onishi T, Tsushima T, Nakazawa H, Oya M, Ozono S, Naito S, Asano T, Members of Japanese Society of Renal Cancer. Clinical outcomes in patients with metastatic papillary renal cell carcinoma: A multiinstitutional study in Japanese Society of Renal Cancer. The 104th Japanease Urological Association Meeting, Sendai. 2016